Pharmacologic treatments for covid-19 patients
Telmisartan vs Standard care
This comparison will not be updated. Last search date 28 Feb, 2022.
Hospitalized patients
Forest plots
(last update: 2021-07-02)
To access all information :
- click here for Hospitalized patients
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=47
Back to your research
| Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
|---|---|---|---|---|---|---|---|---|
| Treatment 1 | Treatment 2 | |||||||
| NCT04355936 Duarte M, EClinicalMedicine, 2021 Full text Commentary |
Mixed |
Telmisartan |
Standard care |
RCT | Patients with confirmed COVID-19 (unclear severity) admitted to 2 centers in Argentina | N=162 |
Some concerns Details |
|